477 related articles for article (PubMed ID: 30396659)
1. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
2. Incidence and tumour characteristics of bilateral and unilateral interval breast cancers at screening mammography.
van Bommel RMG; Voogd AC; Nederend J; Setz-Pels W; Louwman MWJ; Strobbe LJ; Venderink D; Tjan-Heijnen VCG; Duijm LEM
Breast; 2018 Apr; 38():101-106. PubMed ID: 29306176
[TBL] [Abstract][Full Text] [Related]
3. Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study.
Setz-Pels W; Duijm LE; Groenewoud JH; Louwman MW; Jansen FH; van Beek M; Plaisier ML; Voogd AC
Breast Cancer Res Treat; 2011 Oct; 129(3):955-61. PubMed ID: 21553118
[TBL] [Abstract][Full Text] [Related]
4. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
[TBL] [Abstract][Full Text] [Related]
5. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
[TBL] [Abstract][Full Text] [Related]
6. Trends in surgery for screen-detected and interval breast cancers in a national screening programme.
Nederend J; Duijm LE; Louwman MW; Roumen RM; Jansen FH; Voogd AC
Br J Surg; 2014 Jul; 101(8):949-58. PubMed ID: 24828281
[TBL] [Abstract][Full Text] [Related]
7. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
[TBL] [Abstract][Full Text] [Related]
8. Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography.
Lameijer JRC; Coolen AM; Voogd AC; Strobbe LJ; Louwman MWJ; Venderink D; Tjan-Heijnen VC; Duijm LEM
Eur Radiol; 2018 Oct; 28(10):4205-4214. PubMed ID: 29666991
[TBL] [Abstract][Full Text] [Related]
9. Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography.
van Bommel RMG; Weber R; Voogd AC; Nederend J; Louwman MWJ; Venderink D; Strobbe LJA; Rutten MJC; Plaisier ML; Lohle PN; Hooijen MJH; Tjan-Heijnen VCG; Duijm LEM
BMC Cancer; 2017 May; 17(1):315. PubMed ID: 28476109
[TBL] [Abstract][Full Text] [Related]
10. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
11. Frequency and diagnostic outcome of bilateral recall at screening mammography.
Lameijer JRC; Nederend J; Voogd AC; Tjan-Heijnen VCG; Duijm LEM
Int J Cancer; 2021 Jan; 148(1):48-56. PubMed ID: 32621785
[TBL] [Abstract][Full Text] [Related]
12. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of screen-detected cancers following concordant or discordant recalls at blinded double reading in biennial digital screening mammography.
Coolen AMP; Lameijer JRC; Voogd AC; Louwman MWJ; Strobbe LJ; Tjan-Heijnen VCG; Duijm LEM
Eur Radiol; 2019 Jan; 29(1):337-344. PubMed ID: 29943181
[TBL] [Abstract][Full Text] [Related]
14. Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study.
Timmermans L; De Brabander I; Van Damme N; Bleyen L; Martens P; Van Herck K; Thierens H; Bacher K; Depypere H
Maturitas; 2022 Apr; 158():55-60. PubMed ID: 35241239
[TBL] [Abstract][Full Text] [Related]
15. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
16. Detection of bilateral breast cancer at biennial screening mammography in the Netherlands: a population-based study.
Setz-Pels W; Duijm LE; Groenewoud JH; Voogd AC; Jansen FH; Hooijen MJ; Louwman MW
Radiology; 2011 Aug; 260(2):357-63. PubMed ID: 21474705
[TBL] [Abstract][Full Text] [Related]
17. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
18. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.
Chiarelli AM; Edwards SA; Sheppard AJ; Mirea L; Chong N; Paszat L; Shumak RS; Oʼmalley FP;
Eur J Cancer Prev; 2012 Nov; 21(6):499-506. PubMed ID: 22273849
[TBL] [Abstract][Full Text] [Related]
19. Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening.
Caumo F; Romanucci G; Hunter K; Zorzi M; Brunelli S; Macaskill P; Houssami N
Breast Cancer Res Treat; 2018 Jul; 170(2):391-397. PubMed ID: 29557996
[TBL] [Abstract][Full Text] [Related]
20. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
